Læknablaðið - 15.07.1997, Blaðsíða 19

LÆKNABLAÐIÐ 1997; 83
485
6. Richie JP. Surgical aspects in the treatment of patients
with testicular cancer. Hematol/Oncol Clin North Am
1991; 5: U27-42.
7. Guðbjartsson T, Björnsson R, Magnússon K, Björnsson
S, Einarsson GV. Góðar lífshorfur karla með sáð-
krabbamein. Afturskyggn rannsókn á íslenskum körlum
greindum 1971-1990. Læknablaðið 1996; 82: 202-10.
8. Mostofi FK, Sobin LH. Histological Typing of Testis
Tumours. Internationai Histological Classification of
Tumours No. 16. Geneva: WHO 1977.
9. Boden G, Gibb R. Radiotherapy and testicular neo-
plasms. Lancet 1951; 2: 1195-7.
10. Kaplan EL, Meier P. Nonparametric estimation from
incomplete observations. J Am Stat Ass 1958; 53: 457-
81.
11. Taron RE. Test for trend in lifetable analysis. Bio-
metrika 1975; 62: 679-82.
12. Presti JC, Herr HW. Genital tumours. In: Tanagho EA,
McAninch. eds. WJ Smith’s General Urology. 13th ed.
Connecticut: Appleton & Lange, 1992: 413-24.
13. Richie JP. Neoplasms of the testis. In: Walsh PC, ed.
Campbell’s Urology. 6th ed. Pennsylvania: Saunders,
1992: 1239—48.
14. Brodsky GL. Pathology of testicular germ cell tumors.
Hematol/Oncol Clin North Am 1991; 5: 1095-126.
15. Senturia YD. The epidemology and testicular cancer. Br
J Urol 1987; 60: 285-91.
16. Guðlaugsson E, Magnússon B, Hallgrímsson J. Tumors
in Iceland: malignant tumours of the testis. APMIS
1990; 98: 173-8.
17. Aass N, Klepp O, Cavallin-Stahl E, Dahl O. Wicklund
H, Unsgaard B, et al. Prognostic factors in unselected
patients with nonseminomatous metastatic testicular
canser: a multicenter experience. J Clin Onc 1991; 9:
818-26.
18. Fargeot P. Tumeurs germinales du testicule: trois peri-
odes therapeutiques. Bull Cancer 1990; 77: 331-9.
19. Sesterhenn 1A, Weiss RB, Mostofi FK, Stablein DM,
Rowland RG, Falkson G, et al. Prognosis and other
clinical correlates of pathologic review in stage I and II
testicular carcinoma: a report from the testicular cancer
intergroup study. J Clin Onc 1992; 10: 69-78.
20. Mead GM, Stenning SP. Parkinson MC, Horwich A,
Fossá S, Wilkinson PM, et al. The second medical re-
search council study of prognostic factors in nonsemi-
nomatous germ cell tumors. J Clin Onc 1992; 10: 85-94.
21. Sheinfeld J. Nonseminomatous germ cell tumors of the
testis: current concepts and controversies. Urology 1994;
44: 2-14.
22. Stephenson RA. Surveillance for clinical stage I non-
seminomatous testis carcinoma. Urol Int 1991; 46:
290-3.
23. De Riese W, Walker EB, de Riese C, Ulbright TM,
Crabtree WN, Messemer J, et al. Quantitative DNA
measurement by flow cytometry and image analysis of
human nonseminomatous germ cell testicular tumors.
Urol Res 1994; 22: 213-20.
24. Donohue JP, Thornhill JA, Foster RS. Bihrle R, Row-
land RG, Einhorn LH. The role of retroperitoneal lym-
phadenectomy in clinical stage B testis cancer: the Indi-
ana University experience (1965-1989). J Urol 1995; 153:
85-9.
25. Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE,
Henry-Amar M, Fiorentino M, et al. Leukemia follow-
ing Hodgkins disease. N Engl J Med 1990; 322: 7-13.
26. Einhorn LH, Donohue JP. Cis-diamminedichloroplatin,
vinblastine andbleomycin therapy in disseminated tes-
ticular cancer. Ann Intern Med 1977; 87: 293-8.
27. Sternberg CN. Role of primary chemotherapy in stage I
and low-volume stage II nonseminomatous germ-cell
testis tumors. Urol Clin North Am 1993; 20: 93-109.
28. Narayan P, Lange PH, Fraley EE. Ejaculation and fer-
tility after extended retroperitoneal lymph node dis-
section for testicular cancer. J Urol 1982; 127: 685.
29. Richie JP. Clinical stage I testicular cancer: The role of
modified retroperitoneal lymphadenoectomy. J Urol
1990; 144: 1160-3.
30. Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix
A, Droz JP, et al. High dose chemotherapy as salvage
treatment in germ cell tumors: a multivariate analysis of
prognostic variables. J Clin Oncol 1996; 14: 2638-45.
31. Barnett MJ, Coppin CML, Murray N, Nevill TJ, Reece
DE, Klingemann HG, et al. High-dose chemotherapy
and autologous bone marrow transplantation for pa-
tients with poor prognosis nonseminomatous germ cell
tumours. Br J Cancer 1993; 68: 594—8.